抄録
The Y chromosome encodes male-specific minor histocompatibility (H-Y) antigens that stimulate Tand B-lymphocyte responses after sex-mismatched allogeneic hematopoietic cell transplantation (HCT). A CD8 + cytotoxic T lymphocyte (CTL) clone that recognizes a novel HLAB *2705- restricted H-Y antigen encoded by the DDX3Y gene was isolated from a male who had received a hematopoietic cell graft from his human leukocyte antigen (HLA)-identical sister. The antigenic peptide is a decamer that differs from the homologous DDX3X-encoded peptide at 4 positions. Expression of DDX3Y and of the H-Y epitope that it encodes was examined by quantitative polymerase chain reaction (PCR) and by CTL recognition assays. Expression of DDX3Y\s detected in all myeloid and lymphoid leukemic cells that carry an intact Y chromosome. Moreover, the 0DX3V-encoded H-Y epitope is presented on the surface of both myeloid and lymphoid leukemic cells from male HLA-B *2705 + patients. DDX3Yspecific CTLs prevent engraftment of human acute leukemia in nonobese diabetic/severe combined immune deficient mice, demonstrating that the DDX3Y-encoded H-Y antigen is also expressed in leukemic stem cells. These results demonstrate that CD8 + T-cell responses against DDX3Y have the potential to contribute to graft-versus-leukemia (GVL) activity after female into male allogeneic HCT. This study is registered at http://clinicaltrials. gov as NCT00107354.
元の言語 | English |
---|---|
ページ(範囲) | 4817-4826 |
ページ数 | 10 |
ジャーナル | Blood |
巻 | 111 |
発行部数 | 9 |
DOI | |
出版物ステータス | Published - 01-05-2008 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Biochemistry
- Immunology
- Hematology
- Cell Biology
これを引用
}
DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells. / Rosinski, Kellie V.; Fujii, Nobuharu; Mito, Jeffrey K.; Koo, Kevin K.W.; Xuereb, Suzanne M.; Sala-Torra, Olga; Gibbs, James S.; Radich, Jerald P.; Akatsuka, Yoshiki; Van Den Eynde, Benoît J.; Riddell, Stanley R.; Warren, Edus H.
:: Blood, 巻 111, 番号 9, 01.05.2008, p. 4817-4826.研究成果: Article
TY - JOUR
T1 - DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells
AU - Rosinski, Kellie V.
AU - Fujii, Nobuharu
AU - Mito, Jeffrey K.
AU - Koo, Kevin K.W.
AU - Xuereb, Suzanne M.
AU - Sala-Torra, Olga
AU - Gibbs, James S.
AU - Radich, Jerald P.
AU - Akatsuka, Yoshiki
AU - Van Den Eynde, Benoît J.
AU - Riddell, Stanley R.
AU - Warren, Edus H.
PY - 2008/5/1
Y1 - 2008/5/1
N2 - The Y chromosome encodes male-specific minor histocompatibility (H-Y) antigens that stimulate Tand B-lymphocyte responses after sex-mismatched allogeneic hematopoietic cell transplantation (HCT). A CD8 + cytotoxic T lymphocyte (CTL) clone that recognizes a novel HLAB *2705- restricted H-Y antigen encoded by the DDX3Y gene was isolated from a male who had received a hematopoietic cell graft from his human leukocyte antigen (HLA)-identical sister. The antigenic peptide is a decamer that differs from the homologous DDX3X-encoded peptide at 4 positions. Expression of DDX3Y and of the H-Y epitope that it encodes was examined by quantitative polymerase chain reaction (PCR) and by CTL recognition assays. Expression of DDX3Y\s detected in all myeloid and lymphoid leukemic cells that carry an intact Y chromosome. Moreover, the 0DX3V-encoded H-Y epitope is presented on the surface of both myeloid and lymphoid leukemic cells from male HLA-B *2705 + patients. DDX3Yspecific CTLs prevent engraftment of human acute leukemia in nonobese diabetic/severe combined immune deficient mice, demonstrating that the DDX3Y-encoded H-Y antigen is also expressed in leukemic stem cells. These results demonstrate that CD8 + T-cell responses against DDX3Y have the potential to contribute to graft-versus-leukemia (GVL) activity after female into male allogeneic HCT. This study is registered at http://clinicaltrials. gov as NCT00107354.
AB - The Y chromosome encodes male-specific minor histocompatibility (H-Y) antigens that stimulate Tand B-lymphocyte responses after sex-mismatched allogeneic hematopoietic cell transplantation (HCT). A CD8 + cytotoxic T lymphocyte (CTL) clone that recognizes a novel HLAB *2705- restricted H-Y antigen encoded by the DDX3Y gene was isolated from a male who had received a hematopoietic cell graft from his human leukocyte antigen (HLA)-identical sister. The antigenic peptide is a decamer that differs from the homologous DDX3X-encoded peptide at 4 positions. Expression of DDX3Y and of the H-Y epitope that it encodes was examined by quantitative polymerase chain reaction (PCR) and by CTL recognition assays. Expression of DDX3Y\s detected in all myeloid and lymphoid leukemic cells that carry an intact Y chromosome. Moreover, the 0DX3V-encoded H-Y epitope is presented on the surface of both myeloid and lymphoid leukemic cells from male HLA-B *2705 + patients. DDX3Yspecific CTLs prevent engraftment of human acute leukemia in nonobese diabetic/severe combined immune deficient mice, demonstrating that the DDX3Y-encoded H-Y antigen is also expressed in leukemic stem cells. These results demonstrate that CD8 + T-cell responses against DDX3Y have the potential to contribute to graft-versus-leukemia (GVL) activity after female into male allogeneic HCT. This study is registered at http://clinicaltrials. gov as NCT00107354.
UR - http://www.scopus.com/inward/record.url?scp=46049116145&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=46049116145&partnerID=8YFLogxK
U2 - 10.1182/blood-2007-06-096313
DO - 10.1182/blood-2007-06-096313
M3 - Article
C2 - 18299450
AN - SCOPUS:46049116145
VL - 111
SP - 4817
EP - 4826
JO - Blood
JF - Blood
SN - 0006-4971
IS - 9
ER -